A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Biogen Inc. stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 452 shares of BIIB stock, worth $71,370. This represents 0.05% of its overall portfolio holdings.

Number of Shares
452
Previous 452 -0.0%
Holding current value
$71,370
Previous $125,000 -0.0%
% of portfolio
0.05%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$194.69 - $268.46 $87,999 - $121,343
452 New
452 $121,000
Q1 2022

May 02, 2022

SELL
$193.77 - $244.14 $87,584 - $110,351
-452 Closed
0 $0
Q2 2019

Jul 29, 2019

SELL
$219.29 - $241.72 $5,482 - $6,043
-25 Reduced 5.24%
452 $106,000
Q1 2019

Apr 23, 2019

BUY
$216.71 - $338.96 $103,370 - $161,683
477 New
477 $113,000
Q4 2018

Jan 30, 2019

SELL
$278.5 - $352.75 $84,107 - $106,530
-302 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$293.51 - $383.83 $88,640 - $115,916
302 New
302 $107,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Le Jeune Puetz Investment Counsel LLC Portfolio

Follow Le Jeune Puetz Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.